ES488775A1 - Procedimiento para la preparacion de derivados prostanicos - Google Patents

Procedimiento para la preparacion de derivados prostanicos

Info

Publication number
ES488775A1
ES488775A1 ES488775A ES488775A ES488775A1 ES 488775 A1 ES488775 A1 ES 488775A1 ES 488775 A ES488775 A ES 488775A ES 488775 A ES488775 A ES 488775A ES 488775 A1 ES488775 A1 ES 488775A1
Authority
ES
Spain
Prior art keywords
alkyl
aryl
substituted
fluoromethyl
chloromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES488775A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES488775A1 publication Critical patent/ES488775A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)

Abstract

Procedimiento para la preparación de nuevos derivados de prostaciclina, para su utilización en calidad de medicamentos. La prostaciclina (PGI2), uno de los factores principales en la aglomeración de plaquetas sanguíneas, actúa dilatando sobre diferentes vasos sanguíneos y por lo tanto ha de ser considerado como agente de disminución de la tensión sanguínea. No obstante, la PGI2 no posee la necesaria estabilidad para un medicamento. Así, el tiempo se semivida de la PGI2 no posee la necesaria estabilidad para un medicamento. Así, el tiempo de semivida de la PGI2 a valores fisiológicos de pH y a temperatura ambiente es sólo de unos pocos minutos. Se ha encontrado ahora que mediante introducción de enlaces triples y eventualmente de grupos alcohilo en la cadena inferior de la 9-desoxi-9alfa,6-nitrilo-PGF puede conseguirse una más larga duración de efecto, una mayor selectividad y una mejor actividad. Los compuestos obtenidos por el procedimiento tienen efecto hipotensor y broncodilatatorio. Además son apropiados para inhibir la aglomeración de trombocitos.
ES488775A 1979-02-20 1980-02-20 Procedimiento para la preparacion de derivados prostanicos Expired ES488775A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792907118 DE2907118A1 (de) 1979-02-20 1979-02-20 Neue prostacyclin-derivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES488775A1 true ES488775A1 (es) 1980-09-16

Family

ID=6063771

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488775A Expired ES488775A1 (es) 1979-02-20 1980-02-20 Procedimiento para la preparacion de derivados prostanicos

Country Status (14)

Country Link
US (1) US4315013A (es)
EP (1) EP0015227B1 (es)
JP (1) JPS55122759A (es)
AT (1) ATE3420T1 (es)
AU (1) AU540077B2 (es)
CA (1) CA1155114A (es)
CS (1) CS216217B2 (es)
DE (2) DE2907118A1 (es)
DK (1) DK154294C (es)
ES (1) ES488775A1 (es)
HU (1) HU183114B (es)
IE (1) IE49406B1 (es)
IL (1) IL59434A (es)
SU (1) SU976846A3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294759A (en) * 1979-11-15 1981-10-13 The Upjohn Company Structural analogues of 5,6,-dihydro PG1
DE3107100A1 (de) * 1981-02-20 1982-09-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Azaprostacycline, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE3272423D1 (en) * 1981-04-13 1986-09-11 Schering Ag Prostaglandins and prostacyclins, their preparations and pharmaceutical applications
JPS6130519A (ja) * 1984-07-23 1986-02-12 Dainippon Pharmaceut Co Ltd 脳神経細胞の酸素欠乏性疾患治療剤
DE3708537A1 (de) * 1987-03-13 1988-09-22 Schering Ag 6-oxoprostaglandin-e-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
ES2747259T3 (es) 2006-03-09 2020-03-10 Salix Pharmaceuticals Inc Preparación anti-disfunción rectal de rifaximina
RU2012126084A (ru) 2009-11-23 2013-12-27 Сипла Лимитед Пенная композиция для местного применения

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2118686A1 (de) * 1970-04-20 1971-11-11 The Upjohn Co., Kalamazoo, Mich. (V.StA.) Prostaglandinverbindungen und Verfahren zu ihrer Herstellung
CA1018970A (en) * 1972-10-27 1977-10-11 American Home Products Corporation 15-substituted prostanoic acids
GB1458315A (en) * 1974-04-22 1976-12-15 Ici Ltd Prostanoic acid derivatives
US4097489A (en) * 1977-06-17 1978-06-27 The Upjohn Company 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds
US4211706A (en) * 1978-10-13 1980-07-08 The Upjohn Company 9-Deoxy-9α,6-nitrilo or 6,9α-imino-17,18-didehydro-PGF compounds

Also Published As

Publication number Publication date
DK154294B (da) 1988-10-31
IE49406B1 (en) 1985-10-02
IE800326L (en) 1980-08-20
DE3063231D1 (en) 1983-07-07
SU976846A3 (ru) 1982-11-23
AU5574980A (en) 1980-08-28
ATE3420T1 (de) 1983-06-15
HU183114B (en) 1984-04-28
DK154294C (da) 1989-07-03
CA1155114A (en) 1983-10-11
DE2907118A1 (de) 1980-09-04
JPS6248668B2 (es) 1987-10-15
EP0015227A1 (de) 1980-09-03
DK71680A (da) 1980-08-21
US4315013A (en) 1982-02-09
IL59434A0 (en) 1980-05-30
EP0015227B1 (de) 1983-05-18
IL59434A (en) 1984-07-31
JPS55122759A (en) 1980-09-20
CS216217B2 (en) 1982-10-29
AU540077B2 (en) 1984-11-01

Similar Documents

Publication Publication Date Title
YU41668B (en) Process for obtaining prostane derivatives
SE7908481L (sv) Nya 5h-2,3-bensodiazepinderivat och forfarande for framstellning derav
SE8301178D0 (sv) Nya cefalosporinderivat och forfarande for framstellning derav
DE3063231D1 (en) Prostacylin derivatives and process for their preparation
IE790038L (en) 1-azabicyclo £2.2.2| octane (quinuclidine) derivatives.
ZA807819B (en) Benzothiazole derivatives, pharmaceutical formulations containing them and a process for their preparation
JPS51141896A (en) Process for preparing fused ring triazoropyrimidine derivatives
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ES8206550A1 (es) Un procedimiento para la preparacion de derivados de 2-desoxi-3-5-di-o-alquilcarbonil-5-fluorurina.
IE811212L (en) Substituted phenoxy-aminopropanol derivatives
SE7607021L (sv) Alkin-derivat och forfarande for framstellning derav
AU5006679A (en) Pyrano (3,2-c)quinoline derivatives
IE41906L (en) But-2-enoanilides
JPS5242897A (en) Preparation of novel pyridothiadiazine derivatives
SE7704584L (sv) Forfarande for framstellning av nya morfolinderivat
JPS51136656A (en) Process for preparation of novel cyclopropylmethylamine derivatives
JPS5225750A (en) Preparation of prostaglandin derivatives
GB2022583A (en) New ionic polyiodo benzene derivatives useful as X-ray contrast media